 Jennifer Kugel
Concepts (227)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| RNA Polymerase II | 32 | 2021 | 284 | 5.930 |
Why?
| | Transcription, Genetic | 37 | 2023 | 1313 | 4.920 |
Why?
| | RNA, Untranslated | 15 | 2016 | 113 | 3.520 |
Why?
| | Promoter Regions, Genetic | 26 | 2021 | 1131 | 2.640 |
Why?
| | DNA | 21 | 2023 | 1352 | 2.460 |
Why?
| | RNA, Messenger | 12 | 2020 | 2553 | 1.560 |
Why?
| | HMGB1 Protein | 3 | 2022 | 48 | 1.470 |
Why?
| | DNA-Binding Proteins | 7 | 2023 | 1314 | 1.340 |
Why?
| | Nucleic Acid Conformation | 14 | 2020 | 669 | 1.330 |
Why?
| | Protein Binding | 16 | 2023 | 1890 | 1.210 |
Why?
| | RNA | 10 | 2020 | 809 | 1.150 |
Why?
| | Tumor Suppressor Protein p53 | 3 | 2023 | 445 | 1.120 |
Why?
| | Electrophoretic Mobility Shift Assay | 3 | 2023 | 72 | 1.080 |
Why?
| | TATA-Box Binding Protein | 5 | 2013 | 19 | 1.060 |
Why?
| | Heat-Shock Response | 4 | 2018 | 46 | 1.020 |
Why?
| | Gene Expression Regulation | 11 | 2020 | 2320 | 1.010 |
Why?
| | Fluorescence Resonance Energy Transfer | 5 | 2016 | 170 | 0.980 |
Why?
| | Single Molecule Imaging | 3 | 2020 | 30 | 0.930 |
Why?
| | Transcription Factor TFIIB | 5 | 2020 | 13 | 0.910 |
Why?
| | Herpesvirus 1, Human | 2 | 2021 | 76 | 0.830 |
Why?
| | TATA Box | 5 | 2017 | 22 | 0.810 |
Why?
| | Transcription Factor TFIIH | 5 | 2011 | 34 | 0.800 |
Why?
| | Transcription Factors, TFII | 8 | 2016 | 37 | 0.790 |
Why?
| | HMGB2 Protein | 1 | 2021 | 4 | 0.780 |
Why?
| | HMGB Proteins | 1 | 2021 | 15 | 0.770 |
Why?
| | Immediate-Early Proteins | 1 | 2021 | 52 | 0.750 |
Why?
| | Tumor Suppressor Proteins | 1 | 2023 | 282 | 0.740 |
Why?
| | Herpes Simplex | 1 | 2021 | 87 | 0.710 |
Why?
| | Escherichia coli | 2 | 2023 | 720 | 0.700 |
Why?
| | Gene Knockout Techniques | 1 | 2020 | 98 | 0.670 |
Why?
| | TATA-Binding Protein Associated Factors | 2 | 2010 | 15 | 0.660 |
Why?
| | Muscle Development | 1 | 2020 | 98 | 0.660 |
Why?
| | Proto-Oncogene Proteins c-jun | 3 | 2014 | 47 | 0.650 |
Why?
| | Ethanol | 1 | 2023 | 538 | 0.650 |
Why?
| | Transcription Initiation Site | 2 | 2017 | 40 | 0.630 |
Why?
| | Transcription Termination, Genetic | 1 | 2018 | 12 | 0.620 |
Why?
| | Biochemistry | 2 | 2012 | 40 | 0.600 |
Why?
| | RNA Interference | 1 | 2020 | 433 | 0.600 |
Why?
| | Chromatin | 8 | 2023 | 428 | 0.560 |
Why?
| | Kinetics | 11 | 2020 | 1551 | 0.530 |
Why?
| | Transcription Factors | 5 | 2016 | 1528 | 0.510 |
Why?
| | Aptamers, Nucleotide | 2 | 2014 | 73 | 0.500 |
Why?
| | Genome | 2 | 2010 | 271 | 0.490 |
Why?
| | Proto-Oncogene Proteins c-fos | 3 | 2014 | 164 | 0.490 |
Why?
| | Short Interspersed Nucleotide Elements | 4 | 2010 | 10 | 0.480 |
Why?
| | MicroRNAs | 2 | 2020 | 600 | 0.460 |
Why?
| | Catalytic Domain | 3 | 2013 | 196 | 0.460 |
Why?
| | Base Sequence | 12 | 2017 | 2114 | 0.460 |
Why?
| | DNA Cleavage | 1 | 2013 | 6 | 0.430 |
Why?
| | Alu Elements | 6 | 2014 | 26 | 0.420 |
Why?
| | Interleukin-2 | 6 | 2014 | 413 | 0.400 |
Why?
| | Chromatin Assembly and Disassembly | 1 | 2013 | 88 | 0.400 |
Why?
| | Breast Neoplasms | 1 | 2023 | 1862 | 0.400 |
Why?
| | Gene Silencing | 2 | 2010 | 171 | 0.390 |
Why?
| | Humans | 48 | 2023 | 114699 | 0.390 |
Why?
| | Response Elements | 2 | 2023 | 82 | 0.380 |
Why?
| | Animals | 26 | 2020 | 31708 | 0.380 |
Why?
| | RNA, Long Noncoding | 1 | 2013 | 154 | 0.360 |
Why?
| | Recombinant Fusion Proteins | 2 | 2012 | 616 | 0.350 |
Why?
| | Nucleosomes | 3 | 2021 | 123 | 0.350 |
Why?
| | Transcription Factor TFIID | 2 | 2010 | 21 | 0.350 |
Why?
| | Models, Genetic | 8 | 2018 | 562 | 0.350 |
Why?
| | Eukaryota | 1 | 2010 | 47 | 0.340 |
Why?
| | Saccharomyces cerevisiae Proteins | 1 | 2012 | 333 | 0.330 |
Why?
| | RNA, Bacterial | 2 | 2009 | 174 | 0.330 |
Why?
| | RNA, Small Nuclear | 1 | 2009 | 31 | 0.320 |
Why?
| | NIH 3T3 Cells | 4 | 2018 | 137 | 0.320 |
Why?
| | Models, Biological | 8 | 2013 | 1621 | 0.300 |
Why?
| | Mice | 15 | 2020 | 14871 | 0.290 |
Why?
| | Protein Structure, Tertiary | 1 | 2010 | 796 | 0.290 |
Why?
| | Binding Sites | 7 | 2020 | 1168 | 0.290 |
Why?
| | Chromatin Immunoprecipitation | 3 | 2018 | 128 | 0.270 |
Why?
| | Cell Line | 4 | 2023 | 2637 | 0.260 |
Why?
| | Templates, Genetic | 6 | 2016 | 59 | 0.240 |
Why?
| | Gene Expression Regulation, Bacterial | 1 | 2007 | 285 | 0.240 |
Why?
| | Trans-Activators | 1 | 2006 | 367 | 0.220 |
Why?
| | Ribonuclease III | 3 | 2012 | 34 | 0.210 |
Why?
| | DEAD-box RNA Helicases | 3 | 2012 | 56 | 0.210 |
Why?
| | Breast | 1 | 2023 | 139 | 0.210 |
Why?
| | DNA-Directed RNA Polymerases | 3 | 2009 | 51 | 0.200 |
Why?
| | Oligoribonucleotides | 1 | 2002 | 52 | 0.200 |
Why?
| | NFATC Transcription Factors | 2 | 2013 | 78 | 0.190 |
Why?
| | Cartilage | 1 | 2023 | 182 | 0.190 |
Why?
| | Transcription Factor TFIIA | 3 | 2010 | 8 | 0.170 |
Why?
| | Macular Degeneration | 2 | 2012 | 152 | 0.170 |
Why?
| | Fluorescence | 1 | 2020 | 148 | 0.170 |
Why?
| | Osteochondrosis | 1 | 2019 | 2 | 0.170 |
Why?
| | Poultry Diseases | 1 | 2019 | 10 | 0.170 |
Why?
| | Genome, Human | 1 | 2021 | 347 | 0.170 |
Why?
| | 3' Untranslated Regions | 1 | 2020 | 129 | 0.160 |
Why?
| | Myoblasts | 1 | 2020 | 76 | 0.160 |
Why?
| | High-Throughput Nucleotide Sequencing | 2 | 2020 | 439 | 0.160 |
Why?
| | Cartilage, Articular | 1 | 2023 | 289 | 0.160 |
Why?
| | CRISPR-Cas Systems | 1 | 2020 | 78 | 0.160 |
Why?
| | RNA, Double-Stranded | 1 | 2019 | 44 | 0.160 |
Why?
| | Transcription Factor AP-1 | 3 | 2014 | 80 | 0.160 |
Why?
| | HEK293 Cells | 1 | 2021 | 591 | 0.160 |
Why?
| | Bone Resorption | 1 | 2019 | 73 | 0.160 |
Why?
| | Cleavage And Polyadenylation Specificity Factor | 1 | 2018 | 7 | 0.160 |
Why?
| | DNA Footprinting | 2 | 2010 | 28 | 0.160 |
Why?
| | Osteoblasts | 1 | 2019 | 106 | 0.160 |
Why?
| | Optical Imaging | 1 | 2019 | 54 | 0.160 |
Why?
| | Homeostasis | 1 | 2021 | 573 | 0.150 |
Why?
| | Osteomyelitis | 1 | 2019 | 105 | 0.150 |
Why?
| | Hot Temperature | 3 | 2011 | 302 | 0.140 |
Why?
| | Retinal Pigment Epithelium | 3 | 2012 | 58 | 0.140 |
Why?
| | Histones | 1 | 2022 | 535 | 0.140 |
Why?
| | Down-Regulation | 2 | 2010 | 594 | 0.140 |
Why?
| | Protein Conformation | 2 | 2013 | 805 | 0.140 |
Why?
| | Consensus Sequence | 1 | 2017 | 70 | 0.140 |
Why?
| | Cell Differentiation | 2 | 2023 | 1701 | 0.140 |
Why?
| | Transcription Factors, General | 1 | 2016 | 5 | 0.130 |
Why?
| | Transcription Initiation, Genetic | 1 | 2016 | 11 | 0.130 |
Why?
| | Protein Multimerization | 2 | 2014 | 157 | 0.130 |
Why?
| | Adenosine Triphosphate | 1 | 1998 | 430 | 0.130 |
Why?
| | Binding, Competitive | 2 | 2015 | 193 | 0.130 |
Why?
| | Inflammasomes | 2 | 2019 | 115 | 0.130 |
Why?
| | Protein Domains | 1 | 2016 | 207 | 0.120 |
Why?
| | Staphylococcal Infections | 1 | 2019 | 340 | 0.120 |
Why?
| | Molecular Sequence Data | 6 | 2013 | 2785 | 0.120 |
Why?
| | Fluorescent Dyes | 2 | 2016 | 301 | 0.120 |
Why?
| | SELEX Aptamer Technique | 1 | 2014 | 14 | 0.120 |
Why?
| | Microscopy, Fluorescence | 1 | 2016 | 396 | 0.120 |
Why?
| | HeLa Cells | 3 | 2013 | 562 | 0.120 |
Why?
| | Mammals | 1 | 2016 | 244 | 0.110 |
Why?
| | Optical Tweezers | 1 | 2014 | 18 | 0.110 |
Why?
| | Genes, Reporter | 1 | 2014 | 257 | 0.110 |
Why?
| | Virus Replication | 1 | 2015 | 395 | 0.110 |
Why?
| | In Vitro Techniques | 3 | 2005 | 1016 | 0.110 |
Why?
| | Epigenetic Repression | 1 | 2013 | 3 | 0.110 |
Why?
| | Phosphorylation | 3 | 2014 | 1569 | 0.110 |
Why?
| | Buffers | 1 | 2013 | 53 | 0.100 |
Why?
| | Host-Pathogen Interactions | 1 | 2015 | 295 | 0.100 |
Why?
| | Transcription Elongation, Genetic | 1 | 2013 | 20 | 0.100 |
Why?
| | RNA Stability | 1 | 2013 | 90 | 0.100 |
Why?
| | Oligonucleotides, Antisense | 3 | 2011 | 100 | 0.100 |
Why?
| | Mitogen-Activated Protein Kinase 3 | 1 | 2012 | 146 | 0.100 |
Why?
| | Chromosome Mapping | 1 | 2013 | 487 | 0.100 |
Why?
| | Myeloid Differentiation Factor 88 | 1 | 2012 | 90 | 0.100 |
Why?
| | Mitogen-Activated Protein Kinase 1 | 1 | 2012 | 164 | 0.100 |
Why?
| | Geographic Atrophy | 1 | 2012 | 49 | 0.100 |
Why?
| | Cyclin H | 1 | 2011 | 2 | 0.090 |
Why?
| | Phenanthrenes | 1 | 2011 | 10 | 0.090 |
Why?
| | Gene Expression Regulation, Enzymologic | 1 | 2012 | 270 | 0.090 |
Why?
| | Cell Cycle | 1 | 2014 | 542 | 0.090 |
Why?
| | Diterpenes | 1 | 2011 | 31 | 0.090 |
Why?
| | Serine | 1 | 2011 | 126 | 0.090 |
Why?
| | Yeasts | 1 | 2010 | 49 | 0.090 |
Why?
| | Models, Chemical | 2 | 2003 | 248 | 0.090 |
Why?
| | Isomerism | 1 | 2010 | 43 | 0.090 |
Why?
| | Deoxyribonuclease I | 1 | 2010 | 34 | 0.090 |
Why?
| | Cyclin-Dependent Kinases | 1 | 2011 | 111 | 0.090 |
Why?
| | DNA Helicases | 1 | 2011 | 133 | 0.080 |
Why?
| | RNA Polymerase III | 1 | 2009 | 25 | 0.080 |
Why?
| | Saccharomyces cerevisiae | 1 | 2013 | 476 | 0.080 |
Why?
| | Genomic Imprinting | 1 | 2009 | 32 | 0.080 |
Why?
| | Protein Kinases | 1 | 2011 | 307 | 0.080 |
Why?
| | Actins | 1 | 2011 | 381 | 0.080 |
Why?
| | Gene Regulatory Networks | 1 | 2010 | 228 | 0.080 |
Why?
| | Recombinant Proteins | 4 | 2010 | 1230 | 0.080 |
Why?
| | Drosophila melanogaster | 1 | 2010 | 191 | 0.080 |
Why?
| | Biological Products | 1 | 2011 | 166 | 0.070 |
Why?
| | Blotting, Western | 1 | 2011 | 1147 | 0.070 |
Why?
| | Dose-Response Relationship, Drug | 3 | 2011 | 1842 | 0.070 |
Why?
| | Sigma Factor | 1 | 2007 | 33 | 0.070 |
Why?
| | Cattle | 2 | 2000 | 920 | 0.070 |
Why?
| | Cell Proliferation | 1 | 2014 | 2187 | 0.070 |
Why?
| | Sequence Deletion | 1 | 2007 | 167 | 0.070 |
Why?
| | Peptide Elongation Factor 1 | 1 | 2006 | 8 | 0.070 |
Why?
| | Heat Shock Transcription Factors | 1 | 2006 | 17 | 0.070 |
Why?
| | Dimerization | 1 | 2006 | 176 | 0.060 |
Why?
| | Algorithms | 1 | 2013 | 1470 | 0.060 |
Why?
| | Adenoviridae | 3 | 2005 | 184 | 0.060 |
Why?
| | Cell Nucleus | 2 | 2004 | 554 | 0.060 |
Why?
| | Precipitin Tests | 1 | 2004 | 88 | 0.060 |
Why?
| | Reverse Transcriptase Polymerase Chain Reaction | 1 | 2004 | 923 | 0.050 |
Why?
| | Receptors, Retinoic Acid | 1 | 2022 | 49 | 0.050 |
Why?
| | Jurkat Cells | 2 | 2013 | 128 | 0.050 |
Why?
| | RNA, Transfer | 1 | 2002 | 118 | 0.050 |
Why?
| | Doxorubicin | 1 | 2022 | 285 | 0.050 |
Why?
| | Chondrocytes | 1 | 2023 | 199 | 0.040 |
Why?
| | Models, Molecular | 2 | 2020 | 1369 | 0.040 |
Why?
| | Phenotype | 2 | 2023 | 2797 | 0.040 |
Why?
| | Antineoplastic Agents | 1 | 2011 | 1879 | 0.040 |
Why?
| | Transcriptional Activation | 2 | 2013 | 337 | 0.040 |
Why?
| | Staphylococcus | 1 | 2019 | 69 | 0.040 |
Why?
| | Chickens | 1 | 2019 | 177 | 0.040 |
Why?
| | Tissue Engineering | 1 | 2023 | 364 | 0.040 |
Why?
| | Epigenesis, Genetic | 1 | 2023 | 521 | 0.040 |
Why?
| | DNA, Superhelical | 1 | 1998 | 11 | 0.040 |
Why?
| | Necrosis | 1 | 2019 | 211 | 0.040 |
Why?
| | Cell Survival | 2 | 2011 | 1021 | 0.040 |
Why?
| | Female | 1 | 2023 | 59520 | 0.040 |
Why?
| | Enzyme Assays | 1 | 2016 | 21 | 0.030 |
Why?
| | Enzymes, Immobilized | 1 | 2016 | 25 | 0.030 |
Why?
| | Protein Stability | 1 | 2016 | 157 | 0.030 |
Why?
| | Mutation | 3 | 2013 | 3346 | 0.030 |
Why?
| | Thermodynamics | 2 | 2007 | 382 | 0.030 |
Why?
| | Luciferases | 1 | 2013 | 142 | 0.030 |
Why?
| | Sequence Analysis, DNA | 1 | 2015 | 723 | 0.030 |
Why?
| | Flavonoids | 1 | 2012 | 66 | 0.020 |
Why?
| | Time Factors | 3 | 2009 | 6116 | 0.020 |
Why?
| | Toll-Like Receptors | 1 | 2012 | 167 | 0.020 |
Why?
| | Drugs, Chinese Herbal | 1 | 2011 | 13 | 0.020 |
Why?
| | Epoxy Compounds | 1 | 2011 | 31 | 0.020 |
Why?
| | NLR Family, Pyrin Domain-Containing 3 Protein | 1 | 2012 | 144 | 0.020 |
Why?
| | Transfection | 1 | 2013 | 866 | 0.020 |
Why?
| | Enzyme Activation | 1 | 2012 | 785 | 0.020 |
Why?
| | Adenosine Triphosphatases | 1 | 2011 | 153 | 0.020 |
Why?
| | Disease Models, Animal | 1 | 2019 | 3535 | 0.020 |
Why?
| | Protein Subunits | 1 | 2011 | 201 | 0.020 |
Why?
| | Gene Knockdown Techniques | 1 | 2011 | 301 | 0.020 |
Why?
| | Protein Interaction Domains and Motifs | 1 | 2010 | 129 | 0.020 |
Why?
| | Cell Death | 1 | 2011 | 323 | 0.020 |
Why?
| | Esterification | 1 | 2009 | 12 | 0.020 |
Why?
| | DNA Primers | 1 | 2010 | 510 | 0.020 |
Why?
| | Enzyme Inhibitors | 1 | 2012 | 750 | 0.020 |
Why?
| | Carrier Proteins | 1 | 2012 | 695 | 0.020 |
Why?
| | Sequence Analysis | 1 | 2007 | 35 | 0.020 |
Why?
| | Enhancer Elements, Genetic | 1 | 2007 | 151 | 0.020 |
Why?
| | Plasmids | 1 | 2004 | 343 | 0.010 |
Why?
| | Cells, Cultured | 1 | 2011 | 3886 | 0.010 |
Why?
| | T-Lymphocytes | 1 | 2010 | 1737 | 0.010 |
Why?
| | Genes, Viral | 1 | 2001 | 89 | 0.010 |
Why?
| | Macromolecular Substances | 1 | 2001 | 200 | 0.010 |
Why?
| | Nucleotides | 1 | 2001 | 112 | 0.010 |
Why?
| | Signal Transduction | 1 | 2012 | 4515 | 0.010 |
Why?
|
|
Kugel's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts  Derived automatically from this person's publications. _
Co-Authors People in Profiles who have published with this person. _
Similar People People who share similar concepts with this person. _
Same Department
People who are also in this person's primary department.
Physical Neighbors People whose addresses are nearby this person. _
|